MAKING CANCER EXIT
Dead / Abandoned — Abandoned — after inter partes decision (as of 14 Nov 2024)
What this means for you
This application is over — abandoned 14 Nov 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98325991
- Mark type
- Stylized text
- Filed
- 21 Dec 2023
- Published for opposition
- 27 Aug 2024
- Abandoned
- 14 Nov 2024
- Attorney of record
- KAREN WON
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Research and development in the field of cancer therapeutics; Research and development in the pharmaceutical and biotechnology fields.
Owner
- Kiromic Biopharma, Inc., Houston, TX, US
- Kiromic Biopharma, Inc., Houston, TX, US
Prosecution history
- 14 Nov 2024 — ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION
- 14 Nov 2024 — ABANDONMENT - AFTER INTER PARTES DECISION
- 14 Nov 2024 — OPPOSITION TERMINATED NO. 999999
- 14 Nov 2024 — OPPOSITION SUSTAINED NO. 999999
- 28 Oct 2024 — EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
- 28 Oct 2024 — OPPOSITION INSTITUTED NO. 999999
- 25 Sept 2024 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 27 Aug 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Aug 2024 — PUBLISHED FOR OPPOSITION
- 07 Aug 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 24 Jul 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Jul 2024 — ASSIGNED TO EXAMINER
- 02 Apr 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 21 Dec 2023 — NEW APPLICATION ENTERED